Literature DB >> 25987770

Hemodynamics and vasoactive substance levels during renal congestion that occurs in the anhepatic phase of liver transplantation.

Zhong-Xin Li1, Man-Cai Wang1, You-Cheng Zhang1, Jie Mao1, Mo Chen1, Rui Ni1, Feng-Xian Wei1, Gen-Nian Wang1, Ling-Yi Zhang1.   

Abstract

AIM: To explore hemodynamics and vasoactive substance levels during renal vein congestion that occurs in the anhepatic phase of liver transplantation.
METHODS: New Zealand rabbits received ligation of the hepatic pedicle, supra-hepatic vena cava and infra-hepatic vena cava [anhepatic phase group (APH); n = 8], the renal veins (RVL; n = 8), renal veins and hepatic pedicle [with the inferior vena cava left open) (RVHP; n = 8)], or a sham operation (SOP; n = 8). Hemodynamic parameters (systolic, diastolic, and mean arterial blood pressures) and the levels of serum bradykinin (BK) and angiotensin II (ANGII) were measured at baseline (0 min), and 10 min, 20 min, 30 min, and 45 min after the surgery. Correlation analyses were performed to evaluate the associations between hemodynamic parameters and levels of vasoactive substances.
RESULTS: All experimental groups (APH, RVL, and RVHP) showed significant decreases in hemodynamic parameters (systolic, diastolic, and mean arterial blood pressures) compared to baseline levels, as well as compared to the SOP controls (P < 0.05 for all). In contrast, BK levels were significantly increased compared to baseline in the APH, RVL, and RVHP groups at all time points measured (P < 0.05 for all), whereas no change was observed in the SOP controls. There were no significant differences among the experimental groups for any measure at any time point. Further analyses revealed that systolic, diastolic, and mean arterial blood pressures were all negatively correlated with BK levels, and positively correlated with ANGII levels in the APH, RVL, and RVHP groups (P < 0.05 for all).
CONCLUSION: In the anhepatic phase of orthotopic liver transplantation, renal vein congestion significantly impacts hemodynamic parameters, which correlate with serum BK and ANGII levels.

Entities:  

Keywords:  Anhepatic phase; Hemodynamics; Orthotopic liver transplantation; Renal vein congestion; Vasoactive substances

Mesh:

Substances:

Year:  2015        PMID: 25987770      PMCID: PMC4427669          DOI: 10.3748/wjg.v21.i18.5482

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans.

Authors:  Almerina Biggi; Luisa Musiari; Matteo Iori; Giuseppe De Iaco; Giulia Magnani; Irene Pelloni; Silvana Pinelli; Giovanna M Pelà; Almerico Novarini; Aderville Cabassi; Alberto Montanari
Journal:  J Pharmacol Exp Ther       Date:  2010-05-26       Impact factor: 4.030

Review 2.  Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.

Authors:  Ervin G Erdös; Fulong Tan; Randal A Skidgel
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

3.  Intraoperative hemodialysis during liver transplantation: a decade of experience.

Authors:  Mitra K Nadim; Wanwarat Annanthapanyasut; Lea Matsuoka; Kari Appachu; Mark Boyajian; Lingyun Ji; Ashraf Sedra; Yuri S Genyk
Journal:  Liver Transpl       Date:  2014-07       Impact factor: 5.799

Review 4.  Cardiovascular effects of the angiotensin type 2 receptor.

Authors:  Gabriel Faria-Costa; Adelino Leite-Moreira; Tiago Henriques-Coelho
Journal:  Rev Port Cardiol       Date:  2014-07-31       Impact factor: 1.374

5.  Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation.

Authors:  Luc Massicotte; Michel-Antoine Perrault; André Y Denault; John R Klinck; Danielle Beaulieu; Jean-Denis Roy; Lynda Thibeault; André Roy; Michael McCormack; Pierre Karakiewicz
Journal:  Transplantation       Date:  2010-04-27       Impact factor: 4.939

6.  Acute kidney injury after liver transplantation: incidence and mortality.

Authors:  F Klaus; C Keitel da Silva; G Meinerz; L M Carvalho; J C Goldani; G Cantisani; M L Zanotelli; V Duro Garcia; E Keitel
Journal:  Transplant Proc       Date:  2014 Jul-Aug       Impact factor: 1.066

Review 7.  Renal pericytes: multifunctional cells of the kidneys.

Authors:  Ania Stefańska; A M Stefańska; Bruno Péault; B Péault; John J Mullins; J J Mullins
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

8.  Surgical procedures for a rat model of partial orthotopic liver transplantation with hepatic arterial reconstruction.

Authors:  Kazuyuki Nagai; Shintaro Yagi; Shinji Uemoto; Rene H Tolba
Journal:  J Vis Exp       Date:  2013-03-07       Impact factor: 1.355

9.  Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients.

Authors:  Ramona Nicolau-Raducu; Marina Gitman; Donald Ganier; George E Loss; Ari J Cohen; Hamang Patel; Nigel Girgrah; Krish Sekar; Bobby Nossaman
Journal:  Liver Transpl       Date:  2015-01       Impact factor: 5.799

10.  The comparison of femoral and radial arterial blood pressures during pediatric liver transplantation.

Authors:  Y H Shin; H Y Kim; Y R Kim; J S Yoon; J S Ko; M S Gwak; G S Kim; S-K Lee
Journal:  Transplant Proc       Date:  2013-06       Impact factor: 1.066

View more
  2 in total

1.  Incidence and outcomes of acute kidney injury in patients with hepatocellular carcinoma after liver transplantation.

Authors:  Xiaohong Chen; Xiaoqiang Ding; Bo Shen; Jie Teng; Jianzhou Zou; Ting Wang; Jian Zhou; Nan Chen; Boheng Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-13       Impact factor: 4.553

2.  Non-invasive cardiac output measurement with electrical velocimetry in patients undergoing liver transplantation: comparison of an invasive method with pulmonary thermodilution.

Authors:  De-Jie Wang; I-Shan Lee; An-Hsun Chou; Chun-Yu Chen; Pei-Chi Ting; Yun-Hui Teng; Jr-Rung Lin; Hsin-I Tsai
Journal:  BMC Anesthesiol       Date:  2018-10-02       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.